Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
- Citation:
- Oncogene vol 41 (2) 260-7
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 11
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Bristol-Myers Squibb, Genentech, Pfizer
- Grants:
- U10CA180821, U10CA180882, UG1CA233163, P30CA 014089
- Corr. Author:
- Authors:
- Hiroyuki Arai Andrew Elliott Joshua Millstein Joanne Xiu Fang-Shu Ou Federico Innocenti Jingyuan Wang Francesca Battaglin Priya Jayachandran Natsuko Kawanishi Shivani Soni Wu Zhang Davendra Sohal Richard M. Goldberg Michael J. Hall Aaron J Scott Mohd Khushman Jimmy J. Hwang Emil Lou Benjamin A. Weinberg Albert Craig Lockhart Anthony Frank Shields Jim P. Abraham Daniel Magee Phillip Stafford Jian Zhang Alan P Venook W. Michael Korn Heinz-Josef Lenz
- Networks:
- ADM403, ALLIANCE, CA011, CA136, CA249, FL028, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-OH007, MN022, MUSC, NC042, OH070, WV025
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: